nodes	percent_of_prediction	percent_of_DWPC	metapath
Posaconazole—ABCB1—hematologic cancer	0.195	1	CbGaD
Posaconazole—ABCB1—Lenalidomide—hematologic cancer	0.0341	0.0698	CbGbCtD
Posaconazole—CYP3A4—Bexarotene—hematologic cancer	0.0204	0.0418	CbGbCtD
Posaconazole—ABCB1—Daunorubicin—hematologic cancer	0.02	0.0409	CbGbCtD
Posaconazole—ABCB1—Alitretinoin—hematologic cancer	0.0196	0.0401	CbGbCtD
Posaconazole—CYP3A4—Lomustine—hematologic cancer	0.019	0.0389	CbGbCtD
Posaconazole—CYP3A4—Busulfan—hematologic cancer	0.019	0.0389	CbGbCtD
Posaconazole—CYP3A4—Thiotepa—hematologic cancer	0.0169	0.0347	CbGbCtD
Posaconazole—ABCB1—Imatinib—hematologic cancer	0.0153	0.0313	CbGbCtD
Posaconazole—ABCB1—Nilotinib—hematologic cancer	0.0139	0.0285	CbGbCtD
Posaconazole—ABCB1—Vinorelbine—hematologic cancer	0.0138	0.0282	CbGbCtD
Posaconazole—CYP3A4—Methoxsalen—hematologic cancer	0.0132	0.0269	CbGbCtD
Posaconazole—CYP3A4—Bortezomib—hematologic cancer	0.0125	0.0256	CbGbCtD
Posaconazole—ABCB1—Dasatinib—hematologic cancer	0.0123	0.0252	CbGbCtD
Posaconazole—ABCB1—Mitoxantrone—hematologic cancer	0.0121	0.0249	CbGbCtD
Posaconazole—CYP3A4—Daunorubicin—hematologic cancer	0.012	0.0245	CbGbCtD
Posaconazole—ABCB1—Betamethasone—hematologic cancer	0.0108	0.0222	CbGbCtD
Posaconazole—ABCB1—Gemcitabine—hematologic cancer	0.0107	0.022	CbGbCtD
Posaconazole—ABCB1—Prednisolone—hematologic cancer	0.0107	0.0219	CbGbCtD
Posaconazole—CYP3A4—Cytarabine—hematologic cancer	0.0106	0.0216	CbGbCtD
Posaconazole—CYP3A4—Teniposide—hematologic cancer	0.0104	0.0213	CbGbCtD
Posaconazole—ABCB1—Prednisone—hematologic cancer	0.0101	0.0207	CbGbCtD
Posaconazole—CYP3A4—Ifosfamide—hematologic cancer	0.0096	0.0197	CbGbCtD
Posaconazole—ABCB1—Irinotecan—hematologic cancer	0.00956	0.0196	CbGbCtD
Posaconazole—CYP3A4—Imatinib—hematologic cancer	0.00917	0.0188	CbGbCtD
Posaconazole—CYP3A4—Ruxolitinib—hematologic cancer	0.00863	0.0177	CbGbCtD
Posaconazole—ABCB1—Vinblastine—hematologic cancer	0.0085	0.0174	CbGbCtD
Posaconazole—ABCB1—Vincristine—hematologic cancer	0.00835	0.0171	CbGbCtD
Posaconazole—CYP3A4—Nilotinib—hematologic cancer	0.00833	0.0171	CbGbCtD
Posaconazole—CYP3A4—Vinorelbine—hematologic cancer	0.00826	0.0169	CbGbCtD
Posaconazole—ABCB1—Cisplatin—hematologic cancer	0.00779	0.016	CbGbCtD
Posaconazole—ABCB1—Etoposide—hematologic cancer	0.00766	0.0157	CbGbCtD
Posaconazole—CYP3A4—Triamcinolone—hematologic cancer	0.00756	0.0155	CbGbCtD
Posaconazole—CYP3A4—Dasatinib—hematologic cancer	0.00736	0.0151	CbGbCtD
Posaconazole—CYP3A4—Mitoxantrone—hematologic cancer	0.00727	0.0149	CbGbCtD
Posaconazole—CYP3A4—Betamethasone—hematologic cancer	0.00648	0.0133	CbGbCtD
Posaconazole—CYP3A4—Prednisolone—hematologic cancer	0.0064	0.0131	CbGbCtD
Posaconazole—ABCB1—Dexamethasone—hematologic cancer	0.00629	0.0129	CbGbCtD
Posaconazole—CYP3A4—Prednisone—hematologic cancer	0.00604	0.0124	CbGbCtD
Posaconazole—CYP3A4—Irinotecan—hematologic cancer	0.00573	0.0117	CbGbCtD
Posaconazole—ABCB1—Doxorubicin—hematologic cancer	0.00522	0.0107	CbGbCtD
Posaconazole—CYP3A4—Vinblastine—hematologic cancer	0.00509	0.0104	CbGbCtD
Posaconazole—ABCB1—Methotrexate—hematologic cancer	0.00506	0.0104	CbGbCtD
Posaconazole—CYP3A4—Vincristine—hematologic cancer	0.00501	0.0103	CbGbCtD
Posaconazole—CYP3A4—Etoposide—hematologic cancer	0.00459	0.0094	CbGbCtD
Posaconazole—CYP3A4—Dexamethasone—hematologic cancer	0.00377	0.00772	CbGbCtD
Posaconazole—CYP3A4—Doxorubicin—hematologic cancer	0.00313	0.00641	CbGbCtD
Posaconazole—Ketoconazole—AR—hematologic cancer	0.000487	0.534	CrCbGaD
Posaconazole—Itraconazole—ABCB1—hematologic cancer	0.000266	0.292	CrCbGaD
Posaconazole—Ketoconazole—ABCB1—hematologic cancer	0.000159	0.175	CrCbGaD
Posaconazole—ABCB1—HIF-1-alpha transcription factor network—TFRC—hematologic cancer	6.24e-05	0.00444	CbGpPWpGaD
Posaconazole—ABCB1—HIF-1-alpha transcription factor network—EPO—hematologic cancer	6e-05	0.00427	CbGpPWpGaD
Posaconazole—ABCB1—Allograft Rejection—IL13—hematologic cancer	5.87e-05	0.00417	CbGpPWpGaD
Posaconazole—ABCB1—Allograft Rejection—GZMB—hematologic cancer	5.87e-05	0.00417	CbGpPWpGaD
Posaconazole—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—ABL1—hematologic cancer	5.72e-05	0.00407	CbGpPWpGaD
Posaconazole—CYP3A4—Constitutive Androstane Receptor Pathway—HSP90AA1—hematologic cancer	5.72e-05	0.00407	CbGpPWpGaD
Posaconazole—ABCB1—HIF-1-alpha transcription factor network—CXCR4—hematologic cancer	5.59e-05	0.00398	CbGpPWpGaD
Posaconazole—ABCB1—Allograft Rejection—CASP7—hematologic cancer	5.37e-05	0.00382	CbGpPWpGaD
Posaconazole—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRB—hematologic cancer	5.23e-05	0.00372	CbGpPWpGaD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—TOP1—hematologic cancer	5.21e-05	0.0037	CbGpPWpGaD
Posaconazole—ABCB1—Allograft Rejection—PRKCZ—hematologic cancer	5.2e-05	0.0037	CbGpPWpGaD
Posaconazole—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—hematologic cancer	5.15e-05	0.00366	CbGpPWpGaD
Posaconazole—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—hematologic cancer	4.8e-05	0.00341	CbGpPWpGaD
Posaconazole—ABCB1—Allograft Rejection—CD40—hematologic cancer	4.79e-05	0.00341	CbGpPWpGaD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—RARA—hematologic cancer	4.64e-05	0.0033	CbGpPWpGaD
Posaconazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—hematologic cancer	4.57e-05	0.00325	CbGpPWpGaD
Posaconazole—CYP3A4—Constitutive Androstane Receptor Pathway—FOXO1—hematologic cancer	4.54e-05	0.00323	CbGpPWpGaD
Posaconazole—ABCB1—Allograft Rejection—STAT1—hematologic cancer	4.34e-05	0.00309	CbGpPWpGaD
Posaconazole—ABCB1—Allograft Rejection—HLA-DQA1—hematologic cancer	4.16e-05	0.00296	CbGpPWpGaD
Posaconazole—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—hematologic cancer	3.99e-05	0.00284	CbGpPWpGaD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—BBC3—hematologic cancer	3.84e-05	0.00273	CbGpPWpGaD
Posaconazole—CYP3A4—Biological oxidations—SLC35B2—hematologic cancer	3.81e-05	0.00271	CbGpPWpGaD
Posaconazole—CYP3A4—Metapathway biotransformation—EPHX1—hematologic cancer	3.76e-05	0.00268	CbGpPWpGaD
Posaconazole—ABCB1—Allograft Rejection—CD86—hematologic cancer	3.74e-05	0.00266	CbGpPWpGaD
Posaconazole—ABCB1—HIF-1-alpha transcription factor network—TERT—hematologic cancer	3.74e-05	0.00266	CbGpPWpGaD
Posaconazole—ABCB1—Allograft Rejection—IL10—hematologic cancer	3.67e-05	0.00261	CbGpPWpGaD
Posaconazole—ABCB1—Allograft Rejection—CD40LG—hematologic cancer	3.67e-05	0.00261	CbGpPWpGaD
Posaconazole—ABCB1—Allograft Rejection—IL4—hematologic cancer	3.57e-05	0.00254	CbGpPWpGaD
Posaconazole—ABCB1—Allograft Rejection—PDGFRA—hematologic cancer	3.52e-05	0.0025	CbGpPWpGaD
Posaconazole—ABCB1—Allograft Rejection—HLA-B—hematologic cancer	3.49e-05	0.00248	CbGpPWpGaD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—JUND—hematologic cancer	3.45e-05	0.00245	CbGpPWpGaD
Posaconazole—ABCB1—Allograft Rejection—FASLG—hematologic cancer	3.41e-05	0.00243	CbGpPWpGaD
Posaconazole—ABCB1—Allograft Rejection—FAS—hematologic cancer	3.29e-05	0.00234	CbGpPWpGaD
Posaconazole—ABCB1—Allograft Rejection—IL2RA—hematologic cancer	3.27e-05	0.00233	CbGpPWpGaD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—hematologic cancer	3.27e-05	0.00233	CbGpPWpGaD
Posaconazole—ABCB1—Allograft Rejection—HLA-A—hematologic cancer	3.23e-05	0.0023	CbGpPWpGaD
Posaconazole—ABCB1—Transmembrane transport of small molecules—AQP9—hematologic cancer	3.21e-05	0.00228	CbGpPWpGaD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—hematologic cancer	3.1e-05	0.0022	CbGpPWpGaD
Posaconazole—ABCB1—HIF-1-alpha transcription factor network—FOS—hematologic cancer	3e-05	0.00213	CbGpPWpGaD
Posaconazole—ABCB1—HIF-1-alpha transcription factor network—CREB1—hematologic cancer	3e-05	0.00213	CbGpPWpGaD
Posaconazole—ABCB1—Transmembrane transport of small molecules—FXYD6—hematologic cancer	2.98e-05	0.00212	CbGpPWpGaD
Posaconazole—ABCB1—HIF-1-alpha transcription factor network—CREBBP—hematologic cancer	2.92e-05	0.00208	CbGpPWpGaD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—PML—hematologic cancer	2.91e-05	0.00207	CbGpPWpGaD
Posaconazole—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—hematologic cancer	2.87e-05	0.00204	CbGpPWpGaD
Posaconazole—ABCB1—Allograft Rejection—CD80—hematologic cancer	2.73e-05	0.00194	CbGpPWpGaD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—hematologic cancer	2.66e-05	0.0019	CbGpPWpGaD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—CASP7—hematologic cancer	2.65e-05	0.00189	CbGpPWpGaD
Posaconazole—ABCB1—Allograft Rejection—CASP8—hematologic cancer	2.54e-05	0.00181	CbGpPWpGaD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—hematologic cancer	2.53e-05	0.0018	CbGpPWpGaD
Posaconazole—CYP3A4—Biological oxidations—GSTO1—hematologic cancer	2.46e-05	0.00175	CbGpPWpGaD
Posaconazole—ABCB1—Transmembrane transport of small molecules—S100A10—hematologic cancer	2.43e-05	0.00173	CbGpPWpGaD
Posaconazole—CYP3A4—Metapathway biotransformation—GSTO1—hematologic cancer	2.42e-05	0.00172	CbGpPWpGaD
Posaconazole—CYP3A4—Biological oxidations—UGT1A1—hematologic cancer	2.31e-05	0.00164	CbGpPWpGaD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—hematologic cancer	2.3e-05	0.00164	CbGpPWpGaD
Posaconazole—CYP3A4—Metapathway biotransformation—UGT1A1—hematologic cancer	2.28e-05	0.00162	CbGpPWpGaD
Posaconazole—ABCB1—Transmembrane transport of small molecules—SLC35B2—hematologic cancer	2.26e-05	0.00161	CbGpPWpGaD
Posaconazole—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—hematologic cancer	2.2e-05	0.00156	CbGpPWpGaD
Posaconazole—ABCB1—Allograft Rejection—IFNG—hematologic cancer	2.16e-05	0.00154	CbGpPWpGaD
Posaconazole—ABCB1—HIF-1-alpha transcription factor network—JUN—hematologic cancer	2.15e-05	0.00153	CbGpPWpGaD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—STAT1—hematologic cancer	2.14e-05	0.00152	CbGpPWpGaD
Posaconazole—ABCB1—Transmembrane transport of small molecules—ATP1B1—hematologic cancer	2.12e-05	0.00151	CbGpPWpGaD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—AR—hematologic cancer	2.07e-05	0.00147	CbGpPWpGaD
Posaconazole—CYP3A4—Tryptophan metabolism—MDM2—hematologic cancer	2.04e-05	0.00145	CbGpPWpGaD
Posaconazole—ABCB1—Transmembrane transport of small molecules—SLC26A4—hematologic cancer	2.01e-05	0.00143	CbGpPWpGaD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—GRB2—hematologic cancer	2e-05	0.00143	CbGpPWpGaD
Posaconazole—CYP3A4—Biological oxidations—MTR—hematologic cancer	2e-05	0.00142	CbGpPWpGaD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFA—hematologic cancer	2e-05	0.00142	CbGpPWpGaD
Posaconazole—ABCB1—HIF-1-alpha transcription factor network—EP300—hematologic cancer	1.99e-05	0.00141	CbGpPWpGaD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—ABL1—hematologic cancer	1.93e-05	0.00137	CbGpPWpGaD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—STAT5A—hematologic cancer	1.93e-05	0.00137	CbGpPWpGaD
Posaconazole—ABCB1—Allograft Rejection—IL1B—hematologic cancer	1.93e-05	0.00137	CbGpPWpGaD
Posaconazole—ABCB1—Allograft Rejection—CASP3—hematologic cancer	1.92e-05	0.00137	CbGpPWpGaD
Posaconazole—ABCB1—Allograft Rejection—IL2—hematologic cancer	1.92e-05	0.00136	CbGpPWpGaD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—hematologic cancer	1.91e-05	0.00136	CbGpPWpGaD
Posaconazole—CYP3A4—Biological oxidations—GSTT1—hematologic cancer	1.91e-05	0.00136	CbGpPWpGaD
Posaconazole—ABCB1—HIF-1-alpha transcription factor network—VEGFA—hematologic cancer	1.88e-05	0.00134	CbGpPWpGaD
Posaconazole—ABCB1—Transmembrane transport of small molecules—SGK1—hematologic cancer	1.84e-05	0.00131	CbGpPWpGaD
Posaconazole—ABCB1—Transmembrane transport of small molecules—ANXA2—hematologic cancer	1.84e-05	0.00131	CbGpPWpGaD
Posaconazole—ABCB1—Transmembrane transport of small molecules—ATP4A—hematologic cancer	1.84e-05	0.00131	CbGpPWpGaD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—FGF1—hematologic cancer	1.79e-05	0.00127	CbGpPWpGaD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—hematologic cancer	1.77e-05	0.00126	CbGpPWpGaD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—hematologic cancer	1.73e-05	0.00123	CbGpPWpGaD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—hematologic cancer	1.68e-05	0.0012	CbGpPWpGaD
Posaconazole—ABCB1—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	1.66e-05	0.00118	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—GMPS—hematologic cancer	1.64e-05	0.00117	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—FTCD—hematologic cancer	1.64e-05	0.00117	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—PHYH—hematologic cancer	1.64e-05	0.00117	CbGpPWpGaD
Posaconazole—ABCB1—Allograft Rejection—VEGFA—hematologic cancer	1.63e-05	0.00116	CbGpPWpGaD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—hematologic cancer	1.62e-05	0.00116	CbGpPWpGaD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—CDK2—hematologic cancer	1.51e-05	0.00108	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—SMPD3—hematologic cancer	1.5e-05	0.00107	CbGpPWpGaD
Posaconazole—ABCB1—Allograft Rejection—TGFB1—hematologic cancer	1.5e-05	0.00106	CbGpPWpGaD
Posaconazole—ABCB1—Transmembrane transport of small molecules—ABCC3—hematologic cancer	1.46e-05	0.00104	CbGpPWpGaD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK14—hematologic cancer	1.45e-05	0.00103	CbGpPWpGaD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—hematologic cancer	1.43e-05	0.00102	CbGpPWpGaD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—hematologic cancer	1.43e-05	0.00102	CbGpPWpGaD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—hematologic cancer	1.42e-05	0.00101	CbGpPWpGaD
Posaconazole—ABCB1—Allograft Rejection—TNF—hematologic cancer	1.4e-05	0.000994	CbGpPWpGaD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—hematologic cancer	1.39e-05	0.000988	CbGpPWpGaD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—hematologic cancer	1.39e-05	0.000988	CbGpPWpGaD
Posaconazole—ABCB1—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	1.33e-05	0.000947	CbGpPWpGaD
Posaconazole—CYP3A4—Biological oxidations—GSTP1—hematologic cancer	1.32e-05	0.000939	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—DCK—hematologic cancer	1.31e-05	0.000934	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—ASNS—hematologic cancer	1.31e-05	0.000934	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—B3GAT1—hematologic cancer	1.31e-05	0.000934	CbGpPWpGaD
Posaconazole—CYP3A4—Metapathway biotransformation—GSTP1—hematologic cancer	1.3e-05	0.000927	CbGpPWpGaD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—CREB1—hematologic cancer	1.28e-05	0.000911	CbGpPWpGaD
Posaconazole—ABCB1—Transmembrane transport of small molecules—NUP98—hematologic cancer	1.26e-05	0.000894	CbGpPWpGaD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—hematologic cancer	1.25e-05	0.000891	CbGpPWpGaD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—hematologic cancer	1.25e-05	0.000887	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—HDC—hematologic cancer	1.24e-05	0.000885	CbGpPWpGaD
Posaconazole—ABCB1—Transmembrane transport of small molecules—ADCY7—hematologic cancer	1.22e-05	0.000868	CbGpPWpGaD
Posaconazole—CYP3A4—Biological oxidations—GSTM1—hematologic cancer	1.21e-05	0.000863	CbGpPWpGaD
Posaconazole—ABCB1—Transmembrane transport of small molecules—NUP214—hematologic cancer	1.21e-05	0.000862	CbGpPWpGaD
Posaconazole—ABCB1—HIF-1-alpha transcription factor network—AKT1—hematologic cancer	1.2e-05	0.000854	CbGpPWpGaD
Posaconazole—CYP3A4—Metapathway biotransformation—GSTM1—hematologic cancer	1.2e-05	0.000851	CbGpPWpGaD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—MAP2K1—hematologic cancer	1.19e-05	0.000847	CbGpPWpGaD
Posaconazole—ABCB1—Transmembrane transport of small molecules—ABCG2—hematologic cancer	1.19e-05	0.000844	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—CDA—hematologic cancer	1.14e-05	0.00081	CbGpPWpGaD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—hematologic cancer	1.13e-05	0.000805	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—PC—hematologic cancer	1.1e-05	0.00078	CbGpPWpGaD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—hematologic cancer	1.07e-05	0.000765	CbGpPWpGaD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—hematologic cancer	1.06e-05	0.000754	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—GBA—hematologic cancer	1.06e-05	0.000753	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—SLC35B2—hematologic cancer	1.06e-05	0.000753	CbGpPWpGaD
Posaconazole—ABCB1—Transmembrane transport of small molecules—TFRC—hematologic cancer	1.06e-05	0.000753	CbGpPWpGaD
Posaconazole—Anorexia—Prednisone—hematologic cancer	1.03e-05	3.42e-05	CcSEcCtD
Posaconazole—Eye disorder—Doxorubicin—hematologic cancer	1.03e-05	3.42e-05	CcSEcCtD
Posaconazole—Ill-defined disorder—Methotrexate—hematologic cancer	1.03e-05	3.41e-05	CcSEcCtD
Posaconazole—Tinnitus—Doxorubicin—hematologic cancer	1.03e-05	3.41e-05	CcSEcCtD
Posaconazole—Anaemia—Methotrexate—hematologic cancer	1.02e-05	3.4e-05	CcSEcCtD
Posaconazole—Feeling abnormal—Betamethasone—hematologic cancer	1.02e-05	3.4e-05	CcSEcCtD
Posaconazole—Feeling abnormal—Dexamethasone—hematologic cancer	1.02e-05	3.4e-05	CcSEcCtD
Posaconazole—Flushing—Doxorubicin—hematologic cancer	1.02e-05	3.39e-05	CcSEcCtD
Posaconazole—Cardiac disorder—Doxorubicin—hematologic cancer	1.02e-05	3.39e-05	CcSEcCtD
Posaconazole—Flatulence—Epirubicin—hematologic cancer	1.02e-05	3.39e-05	CcSEcCtD
Posaconazole—Gastrointestinal pain—Dexamethasone—hematologic cancer	1.02e-05	3.37e-05	CcSEcCtD
Posaconazole—Gastrointestinal pain—Betamethasone—hematologic cancer	1.02e-05	3.37e-05	CcSEcCtD
Posaconazole—Dysgeusia—Epirubicin—hematologic cancer	1.02e-05	3.37e-05	CcSEcCtD
Posaconazole—CYP3A4—Metabolism—FTCD—hematologic cancer	1.01e-05	0.00072	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—PHYH—hematologic cancer	1.01e-05	0.00072	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—GMPS—hematologic cancer	1.01e-05	0.00072	CbGpPWpGaD
Posaconazole—Hypersensitivity—Triamcinolone—hematologic cancer	1.01e-05	3.35e-05	CcSEcCtD
Posaconazole—Back pain—Epirubicin—hematologic cancer	1e-05	3.33e-05	CcSEcCtD
Posaconazole—Angiopathy—Doxorubicin—hematologic cancer	1e-05	3.32e-05	CcSEcCtD
Posaconazole—Malaise—Methotrexate—hematologic cancer	1e-05	3.31e-05	CcSEcCtD
Posaconazole—Dizziness—Etoposide—hematologic cancer	9.99e-06	3.31e-05	CcSEcCtD
Posaconazole—Muscle spasms—Epirubicin—hematologic cancer	9.97e-06	3.31e-05	CcSEcCtD
Posaconazole—Immune system disorder—Doxorubicin—hematologic cancer	9.96e-06	3.3e-05	CcSEcCtD
Posaconazole—Vertigo—Methotrexate—hematologic cancer	9.96e-06	3.3e-05	CcSEcCtD
Posaconazole—Mediastinal disorder—Doxorubicin—hematologic cancer	9.94e-06	3.29e-05	CcSEcCtD
Posaconazole—Leukopenia—Methotrexate—hematologic cancer	9.92e-06	3.29e-05	CcSEcCtD
Posaconazole—Chills—Doxorubicin—hematologic cancer	9.89e-06	3.28e-05	CcSEcCtD
Posaconazole—Urticaria—Betamethasone—hematologic cancer	9.88e-06	3.27e-05	CcSEcCtD
Posaconazole—Urticaria—Dexamethasone—hematologic cancer	9.88e-06	3.27e-05	CcSEcCtD
Posaconazole—Musculoskeletal discomfort—Prednisone—hematologic cancer	9.86e-06	3.27e-05	CcSEcCtD
Posaconazole—Dizziness—Prednisolone—hematologic cancer	9.85e-06	3.27e-05	CcSEcCtD
Posaconazole—Arrhythmia—Doxorubicin—hematologic cancer	9.85e-06	3.27e-05	CcSEcCtD
Posaconazole—Asthenia—Triamcinolone—hematologic cancer	9.83e-06	3.26e-05	CcSEcCtD
Posaconazole—Abdominal pain—Dexamethasone—hematologic cancer	9.83e-06	3.26e-05	CcSEcCtD
Posaconazole—Abdominal pain—Betamethasone—hematologic cancer	9.83e-06	3.26e-05	CcSEcCtD
Posaconazole—Body temperature increased—Betamethasone—hematologic cancer	9.83e-06	3.26e-05	CcSEcCtD
Posaconazole—Body temperature increased—Dexamethasone—hematologic cancer	9.83e-06	3.26e-05	CcSEcCtD
Posaconazole—Nausea—Cisplatin—hematologic cancer	9.79e-06	3.25e-05	CcSEcCtD
Posaconazole—Insomnia—Prednisone—hematologic cancer	9.79e-06	3.25e-05	CcSEcCtD
Posaconazole—Vision blurred—Epirubicin—hematologic cancer	9.78e-06	3.24e-05	CcSEcCtD
Posaconazole—Alopecia—Doxorubicin—hematologic cancer	9.74e-06	3.23e-05	CcSEcCtD
Posaconazole—Paraesthesia—Prednisone—hematologic cancer	9.72e-06	3.22e-05	CcSEcCtD
Posaconazole—Pruritus—Triamcinolone—hematologic cancer	9.69e-06	3.21e-05	CcSEcCtD
Posaconazole—ABCB1—Metabolism—MTAP—hematologic cancer	9.68e-06	0.000689	CbGpPWpGaD
Posaconazole—Cough—Methotrexate—hematologic cancer	9.67e-06	3.21e-05	CcSEcCtD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—hematologic cancer	9.67e-06	0.000688	CbGpPWpGaD
Posaconazole—Mental disorder—Doxorubicin—hematologic cancer	9.66e-06	3.2e-05	CcSEcCtD
Posaconazole—Ill-defined disorder—Epirubicin—hematologic cancer	9.63e-06	3.19e-05	CcSEcCtD
Posaconazole—Convulsion—Methotrexate—hematologic cancer	9.6e-06	3.18e-05	CcSEcCtD
Posaconazole—Vomiting—Etoposide—hematologic cancer	9.6e-06	3.18e-05	CcSEcCtD
Posaconazole—Erythema—Doxorubicin—hematologic cancer	9.6e-06	3.18e-05	CcSEcCtD
Posaconazole—Malnutrition—Doxorubicin—hematologic cancer	9.6e-06	3.18e-05	CcSEcCtD
Posaconazole—Anaemia—Epirubicin—hematologic cancer	9.59e-06	3.18e-05	CcSEcCtD
Posaconazole—Agitation—Epirubicin—hematologic cancer	9.53e-06	3.16e-05	CcSEcCtD
Posaconazole—Dyspepsia—Prednisone—hematologic cancer	9.53e-06	3.16e-05	CcSEcCtD
Posaconazole—Rash—Etoposide—hematologic cancer	9.52e-06	3.16e-05	CcSEcCtD
Posaconazole—Dermatitis—Etoposide—hematologic cancer	9.51e-06	3.15e-05	CcSEcCtD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—hematologic cancer	9.48e-06	0.000674	CbGpPWpGaD
Posaconazole—Headache—Etoposide—hematologic cancer	9.46e-06	3.14e-05	CcSEcCtD
Posaconazole—Flatulence—Doxorubicin—hematologic cancer	9.46e-06	3.14e-05	CcSEcCtD
Posaconazole—Arthralgia—Methotrexate—hematologic cancer	9.44e-06	3.13e-05	CcSEcCtD
Posaconazole—Chest pain—Methotrexate—hematologic cancer	9.44e-06	3.13e-05	CcSEcCtD
Posaconazole—Myalgia—Methotrexate—hematologic cancer	9.44e-06	3.13e-05	CcSEcCtD
Posaconazole—Decreased appetite—Prednisone—hematologic cancer	9.41e-06	3.12e-05	CcSEcCtD
Posaconazole—Dysgeusia—Doxorubicin—hematologic cancer	9.4e-06	3.12e-05	CcSEcCtD
Posaconazole—Rash—Prednisolone—hematologic cancer	9.39e-06	3.11e-05	CcSEcCtD
Posaconazole—Dermatitis—Prednisolone—hematologic cancer	9.38e-06	3.11e-05	CcSEcCtD
Posaconazole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	9.37e-06	3.11e-05	CcSEcCtD
Posaconazole—Malaise—Epirubicin—hematologic cancer	9.36e-06	3.1e-05	CcSEcCtD
Posaconazole—Fatigue—Prednisone—hematologic cancer	9.33e-06	3.09e-05	CcSEcCtD
Posaconazole—Headache—Prednisolone—hematologic cancer	9.33e-06	3.09e-05	CcSEcCtD
Posaconazole—Discomfort—Methotrexate—hematologic cancer	9.32e-06	3.09e-05	CcSEcCtD
Posaconazole—Vertigo—Epirubicin—hematologic cancer	9.32e-06	3.09e-05	CcSEcCtD
Posaconazole—Syncope—Epirubicin—hematologic cancer	9.3e-06	3.08e-05	CcSEcCtD
Posaconazole—Leukopenia—Epirubicin—hematologic cancer	9.29e-06	3.08e-05	CcSEcCtD
Posaconazole—Back pain—Doxorubicin—hematologic cancer	9.28e-06	3.08e-05	CcSEcCtD
Posaconazole—Constipation—Prednisone—hematologic cancer	9.26e-06	3.07e-05	CcSEcCtD
Posaconazole—CYP3A4—Metabolism—SMPD3—hematologic cancer	9.26e-06	0.000658	CbGpPWpGaD
Posaconazole—Muscle spasms—Doxorubicin—hematologic cancer	9.23e-06	3.06e-05	CcSEcCtD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—hematologic cancer	9.23e-06	0.000656	CbGpPWpGaD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—hematologic cancer	9.21e-06	0.000655	CbGpPWpGaD
Posaconazole—Confusional state—Methotrexate—hematologic cancer	9.12e-06	3.02e-05	CcSEcCtD
Posaconazole—Loss of consciousness—Epirubicin—hematologic cancer	9.12e-06	3.02e-05	CcSEcCtD
Posaconazole—Dizziness—Triamcinolone—hematologic cancer	9.06e-06	3e-05	CcSEcCtD
Posaconazole—Cough—Epirubicin—hematologic cancer	9.05e-06	3e-05	CcSEcCtD
Posaconazole—Vision blurred—Doxorubicin—hematologic cancer	9.05e-06	3e-05	CcSEcCtD
Posaconazole—Convulsion—Epirubicin—hematologic cancer	8.99e-06	2.98e-05	CcSEcCtD
Posaconazole—Infection—Methotrexate—hematologic cancer	8.99e-06	2.98e-05	CcSEcCtD
Posaconazole—Nausea—Etoposide—hematologic cancer	8.97e-06	2.97e-05	CcSEcCtD
Posaconazole—Hypertension—Epirubicin—hematologic cancer	8.96e-06	2.97e-05	CcSEcCtD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—hematologic cancer	8.93e-06	0.000635	CbGpPWpGaD
Posaconazole—Feeling abnormal—Prednisone—hematologic cancer	8.92e-06	2.96e-05	CcSEcCtD
Posaconazole—Asthenia—Dexamethasone—hematologic cancer	8.92e-06	2.96e-05	CcSEcCtD
Posaconazole—Asthenia—Betamethasone—hematologic cancer	8.92e-06	2.96e-05	CcSEcCtD
Posaconazole—Ill-defined disorder—Doxorubicin—hematologic cancer	8.91e-06	2.95e-05	CcSEcCtD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—hematologic cancer	8.91e-06	0.000633	CbGpPWpGaD
Posaconazole—ABCB1—Transmembrane transport of small molecules—CYCS—hematologic cancer	8.88e-06	0.000632	CbGpPWpGaD
Posaconazole—Nervous system disorder—Methotrexate—hematologic cancer	8.87e-06	2.94e-05	CcSEcCtD
Posaconazole—Anaemia—Doxorubicin—hematologic cancer	8.87e-06	2.94e-05	CcSEcCtD
Posaconazole—Thrombocytopenia—Methotrexate—hematologic cancer	8.86e-06	2.94e-05	CcSEcCtD
Posaconazole—Gastrointestinal pain—Prednisone—hematologic cancer	8.85e-06	2.93e-05	CcSEcCtD
Posaconazole—Nausea—Prednisolone—hematologic cancer	8.85e-06	2.93e-05	CcSEcCtD
Posaconazole—Myalgia—Epirubicin—hematologic cancer	8.83e-06	2.93e-05	CcSEcCtD
Posaconazole—Chest pain—Epirubicin—hematologic cancer	8.83e-06	2.93e-05	CcSEcCtD
Posaconazole—Arthralgia—Epirubicin—hematologic cancer	8.83e-06	2.93e-05	CcSEcCtD
Posaconazole—Agitation—Doxorubicin—hematologic cancer	8.82e-06	2.92e-05	CcSEcCtD
Posaconazole—Anxiety—Epirubicin—hematologic cancer	8.8e-06	2.92e-05	CcSEcCtD
Posaconazole—Pruritus—Dexamethasone—hematologic cancer	8.79e-06	2.92e-05	CcSEcCtD
Posaconazole—Pruritus—Betamethasone—hematologic cancer	8.79e-06	2.92e-05	CcSEcCtD
Posaconazole—Skin disorder—Methotrexate—hematologic cancer	8.79e-06	2.91e-05	CcSEcCtD
Posaconazole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	8.77e-06	2.91e-05	CcSEcCtD
Posaconazole—Hyperhidrosis—Methotrexate—hematologic cancer	8.75e-06	2.9e-05	CcSEcCtD
Posaconazole—Discomfort—Epirubicin—hematologic cancer	8.73e-06	2.89e-05	CcSEcCtD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—hematologic cancer	8.71e-06	0.00062	CbGpPWpGaD
Posaconazole—Vomiting—Triamcinolone—hematologic cancer	8.71e-06	2.89e-05	CcSEcCtD
Posaconazole—Malaise—Doxorubicin—hematologic cancer	8.66e-06	2.87e-05	CcSEcCtD
Posaconazole—Rash—Triamcinolone—hematologic cancer	8.64e-06	2.86e-05	CcSEcCtD
Posaconazole—Dry mouth—Epirubicin—hematologic cancer	8.64e-06	2.86e-05	CcSEcCtD
Posaconazole—Dermatitis—Triamcinolone—hematologic cancer	8.63e-06	2.86e-05	CcSEcCtD
Posaconazole—ABCB1—Metabolism—FHL2—hematologic cancer	8.63e-06	0.000614	CbGpPWpGaD
Posaconazole—Vertigo—Doxorubicin—hematologic cancer	8.62e-06	2.86e-05	CcSEcCtD
Posaconazole—Anorexia—Methotrexate—hematologic cancer	8.62e-06	2.86e-05	CcSEcCtD
Posaconazole—Syncope—Doxorubicin—hematologic cancer	8.61e-06	2.85e-05	CcSEcCtD
Posaconazole—Urticaria—Prednisone—hematologic cancer	8.6e-06	2.85e-05	CcSEcCtD
Posaconazole—Leukopenia—Doxorubicin—hematologic cancer	8.59e-06	2.85e-05	CcSEcCtD
Posaconazole—Headache—Triamcinolone—hematologic cancer	8.58e-06	2.85e-05	CcSEcCtD
Posaconazole—Abdominal pain—Prednisone—hematologic cancer	8.56e-06	2.84e-05	CcSEcCtD
Posaconazole—Body temperature increased—Prednisone—hematologic cancer	8.56e-06	2.84e-05	CcSEcCtD
Posaconazole—Confusional state—Epirubicin—hematologic cancer	8.54e-06	2.83e-05	CcSEcCtD
Posaconazole—Diarrhoea—Dexamethasone—hematologic cancer	8.51e-06	2.82e-05	CcSEcCtD
Posaconazole—Diarrhoea—Betamethasone—hematologic cancer	8.51e-06	2.82e-05	CcSEcCtD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—hematologic cancer	8.49e-06	0.000604	CbGpPWpGaD
Posaconazole—Oedema—Epirubicin—hematologic cancer	8.47e-06	2.81e-05	CcSEcCtD
Posaconazole—ABCB1—Metabolism—AGRN—hematologic cancer	8.46e-06	0.000602	CbGpPWpGaD
Posaconazole—Hypotension—Methotrexate—hematologic cancer	8.45e-06	2.8e-05	CcSEcCtD
Posaconazole—Loss of consciousness—Doxorubicin—hematologic cancer	8.44e-06	2.8e-05	CcSEcCtD
Posaconazole—Infection—Epirubicin—hematologic cancer	8.41e-06	2.79e-05	CcSEcCtD
Posaconazole—Cough—Doxorubicin—hematologic cancer	8.38e-06	2.78e-05	CcSEcCtD
Posaconazole—Shock—Epirubicin—hematologic cancer	8.33e-06	2.76e-05	CcSEcCtD
Posaconazole—Convulsion—Doxorubicin—hematologic cancer	8.32e-06	2.76e-05	CcSEcCtD
Posaconazole—Nervous system disorder—Epirubicin—hematologic cancer	8.3e-06	2.75e-05	CcSEcCtD
Posaconazole—Thrombocytopenia—Epirubicin—hematologic cancer	8.29e-06	2.75e-05	CcSEcCtD
Posaconazole—Hypertension—Doxorubicin—hematologic cancer	8.29e-06	2.75e-05	CcSEcCtD
Posaconazole—Tachycardia—Epirubicin—hematologic cancer	8.26e-06	2.74e-05	CcSEcCtD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—hematologic cancer	8.26e-06	0.000587	CbGpPWpGaD
Posaconazole—Musculoskeletal discomfort—Methotrexate—hematologic cancer	8.24e-06	2.73e-05	CcSEcCtD
Posaconazole—Skin disorder—Epirubicin—hematologic cancer	8.22e-06	2.73e-05	CcSEcCtD
Posaconazole—Dizziness—Dexamethasone—hematologic cancer	8.22e-06	2.73e-05	CcSEcCtD
Posaconazole—Dizziness—Betamethasone—hematologic cancer	8.22e-06	2.73e-05	CcSEcCtD
Posaconazole—Hyperhidrosis—Epirubicin—hematologic cancer	8.18e-06	2.71e-05	CcSEcCtD
Posaconazole—Insomnia—Methotrexate—hematologic cancer	8.18e-06	2.71e-05	CcSEcCtD
Posaconazole—Arthralgia—Doxorubicin—hematologic cancer	8.17e-06	2.71e-05	CcSEcCtD
Posaconazole—Chest pain—Doxorubicin—hematologic cancer	8.17e-06	2.71e-05	CcSEcCtD
Posaconazole—Myalgia—Doxorubicin—hematologic cancer	8.17e-06	2.71e-05	CcSEcCtD
Posaconazole—Anxiety—Doxorubicin—hematologic cancer	8.14e-06	2.7e-05	CcSEcCtD
Posaconazole—Nausea—Triamcinolone—hematologic cancer	8.14e-06	2.7e-05	CcSEcCtD
Posaconazole—Paraesthesia—Methotrexate—hematologic cancer	8.12e-06	2.69e-05	CcSEcCtD
Posaconazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	8.12e-06	2.69e-05	CcSEcCtD
Posaconazole—CYP3A4—Metabolism—B3GAT1—hematologic cancer	8.09e-06	0.000575	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—DCK—hematologic cancer	8.09e-06	0.000575	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—ASNS—hematologic cancer	8.09e-06	0.000575	CbGpPWpGaD
Posaconazole—Discomfort—Doxorubicin—hematologic cancer	8.07e-06	2.68e-05	CcSEcCtD
Posaconazole—Anorexia—Epirubicin—hematologic cancer	8.07e-06	2.68e-05	CcSEcCtD
Posaconazole—Dyspnoea—Methotrexate—hematologic cancer	8.07e-06	2.67e-05	CcSEcCtD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—hematologic cancer	8.04e-06	0.000572	CbGpPWpGaD
Posaconazole—Somnolence—Methotrexate—hematologic cancer	8.04e-06	2.67e-05	CcSEcCtD
Posaconazole—ABCB1—Metabolism—HMMR—hematologic cancer	8.02e-06	0.000571	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—IDH2—hematologic cancer	8.02e-06	0.000571	CbGpPWpGaD
Posaconazole—Dry mouth—Doxorubicin—hematologic cancer	7.99e-06	2.65e-05	CcSEcCtD
Posaconazole—Hypersensitivity—Prednisone—hematologic cancer	7.98e-06	2.64e-05	CcSEcCtD
Posaconazole—Dyspepsia—Methotrexate—hematologic cancer	7.96e-06	2.64e-05	CcSEcCtD
Posaconazole—Hypotension—Epirubicin—hematologic cancer	7.91e-06	2.62e-05	CcSEcCtD
Posaconazole—Vomiting—Dexamethasone—hematologic cancer	7.9e-06	2.62e-05	CcSEcCtD
Posaconazole—Vomiting—Betamethasone—hematologic cancer	7.9e-06	2.62e-05	CcSEcCtD
Posaconazole—Confusional state—Doxorubicin—hematologic cancer	7.9e-06	2.62e-05	CcSEcCtD
Posaconazole—Decreased appetite—Methotrexate—hematologic cancer	7.86e-06	2.61e-05	CcSEcCtD
Posaconazole—Rash—Dexamethasone—hematologic cancer	7.84e-06	2.6e-05	CcSEcCtD
Posaconazole—Rash—Betamethasone—hematologic cancer	7.84e-06	2.6e-05	CcSEcCtD
Posaconazole—Oedema—Doxorubicin—hematologic cancer	7.83e-06	2.6e-05	CcSEcCtD
Posaconazole—Dermatitis—Betamethasone—hematologic cancer	7.83e-06	2.6e-05	CcSEcCtD
Posaconazole—Dermatitis—Dexamethasone—hematologic cancer	7.83e-06	2.6e-05	CcSEcCtD
Posaconazole—Gastrointestinal disorder—Methotrexate—hematologic cancer	7.81e-06	2.59e-05	CcSEcCtD
Posaconazole—Fatigue—Methotrexate—hematologic cancer	7.8e-06	2.59e-05	CcSEcCtD
Posaconazole—Headache—Dexamethasone—hematologic cancer	7.79e-06	2.58e-05	CcSEcCtD
Posaconazole—Headache—Betamethasone—hematologic cancer	7.79e-06	2.58e-05	CcSEcCtD
Posaconazole—Infection—Doxorubicin—hematologic cancer	7.78e-06	2.58e-05	CcSEcCtD
Posaconazole—Asthenia—Prednisone—hematologic cancer	7.77e-06	2.57e-05	CcSEcCtD
Posaconazole—Pain—Methotrexate—hematologic cancer	7.74e-06	2.56e-05	CcSEcCtD
Posaconazole—Musculoskeletal discomfort—Epirubicin—hematologic cancer	7.71e-06	2.56e-05	CcSEcCtD
Posaconazole—Shock—Doxorubicin—hematologic cancer	7.71e-06	2.56e-05	CcSEcCtD
Posaconazole—Nervous system disorder—Doxorubicin—hematologic cancer	7.68e-06	2.55e-05	CcSEcCtD
Posaconazole—Thrombocytopenia—Doxorubicin—hematologic cancer	7.67e-06	2.54e-05	CcSEcCtD
Posaconazole—CYP3A4—Metabolism—HDC—hematologic cancer	7.67e-06	0.000546	CbGpPWpGaD
Posaconazole—Pruritus—Prednisone—hematologic cancer	7.66e-06	2.54e-05	CcSEcCtD
Posaconazole—Insomnia—Epirubicin—hematologic cancer	7.66e-06	2.54e-05	CcSEcCtD
Posaconazole—Tachycardia—Doxorubicin—hematologic cancer	7.65e-06	2.53e-05	CcSEcCtD
Posaconazole—Skin disorder—Doxorubicin—hematologic cancer	7.61e-06	2.52e-05	CcSEcCtD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—hematologic cancer	7.61e-06	0.000541	CbGpPWpGaD
Posaconazole—Paraesthesia—Epirubicin—hematologic cancer	7.6e-06	2.52e-05	CcSEcCtD
Posaconazole—Hyperhidrosis—Doxorubicin—hematologic cancer	7.57e-06	2.51e-05	CcSEcCtD
Posaconazole—Dyspnoea—Epirubicin—hematologic cancer	7.55e-06	2.5e-05	CcSEcCtD
Posaconazole—ABCB1—Metabolism—ARNTL—hematologic cancer	7.54e-06	0.000536	CbGpPWpGaD
Posaconazole—Somnolence—Epirubicin—hematologic cancer	7.53e-06	2.5e-05	CcSEcCtD
Posaconazole—Anorexia—Doxorubicin—hematologic cancer	7.47e-06	2.48e-05	CcSEcCtD
Posaconazole—Feeling abnormal—Methotrexate—hematologic cancer	7.46e-06	2.47e-05	CcSEcCtD
Posaconazole—Dyspepsia—Epirubicin—hematologic cancer	7.45e-06	2.47e-05	CcSEcCtD
Posaconazole—Diarrhoea—Prednisone—hematologic cancer	7.41e-06	2.46e-05	CcSEcCtD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—hematologic cancer	7.4e-06	0.000526	CbGpPWpGaD
Posaconazole—Gastrointestinal pain—Methotrexate—hematologic cancer	7.4e-06	2.45e-05	CcSEcCtD
Posaconazole—Nausea—Betamethasone—hematologic cancer	7.38e-06	2.45e-05	CcSEcCtD
Posaconazole—Nausea—Dexamethasone—hematologic cancer	7.38e-06	2.45e-05	CcSEcCtD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—hematologic cancer	7.38e-06	0.000525	CbGpPWpGaD
Posaconazole—Decreased appetite—Epirubicin—hematologic cancer	7.36e-06	2.44e-05	CcSEcCtD
Posaconazole—ABCB1—Metabolism—ACP5—hematologic cancer	7.34e-06	0.000522	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—CA9—hematologic cancer	7.34e-06	0.000522	CbGpPWpGaD
Posaconazole—Hypotension—Doxorubicin—hematologic cancer	7.32e-06	2.43e-05	CcSEcCtD
Posaconazole—Gastrointestinal disorder—Epirubicin—hematologic cancer	7.31e-06	2.42e-05	CcSEcCtD
Posaconazole—Fatigue—Epirubicin—hematologic cancer	7.3e-06	2.42e-05	CcSEcCtD
Posaconazole—ABCB1—Metabolism—NCOR2—hematologic cancer	7.24e-06	0.000515	CbGpPWpGaD
Posaconazole—Pain—Epirubicin—hematologic cancer	7.24e-06	2.4e-05	CcSEcCtD
Posaconazole—Constipation—Epirubicin—hematologic cancer	7.24e-06	2.4e-05	CcSEcCtD
Posaconazole—Urticaria—Methotrexate—hematologic cancer	7.19e-06	2.38e-05	CcSEcCtD
Posaconazole—Dizziness—Prednisone—hematologic cancer	7.16e-06	2.37e-05	CcSEcCtD
Posaconazole—Abdominal pain—Methotrexate—hematologic cancer	7.15e-06	2.37e-05	CcSEcCtD
Posaconazole—Body temperature increased—Methotrexate—hematologic cancer	7.15e-06	2.37e-05	CcSEcCtD
Posaconazole—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	7.14e-06	2.37e-05	CcSEcCtD
Posaconazole—Insomnia—Doxorubicin—hematologic cancer	7.09e-06	2.35e-05	CcSEcCtD
Posaconazole—Paraesthesia—Doxorubicin—hematologic cancer	7.03e-06	2.33e-05	CcSEcCtD
Posaconazole—CYP3A4—Metabolism—CDA—hematologic cancer	7.01e-06	0.000499	CbGpPWpGaD
Posaconazole—Dyspnoea—Doxorubicin—hematologic cancer	6.98e-06	2.32e-05	CcSEcCtD
Posaconazole—Feeling abnormal—Epirubicin—hematologic cancer	6.98e-06	2.31e-05	CcSEcCtD
Posaconazole—Somnolence—Doxorubicin—hematologic cancer	6.96e-06	2.31e-05	CcSEcCtD
Posaconazole—Gastrointestinal pain—Epirubicin—hematologic cancer	6.92e-06	2.3e-05	CcSEcCtD
Posaconazole—ABCB1—Metabolism—IDH1—hematologic cancer	6.9e-06	0.000491	CbGpPWpGaD
Posaconazole—Dyspepsia—Doxorubicin—hematologic cancer	6.9e-06	2.29e-05	CcSEcCtD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—hematologic cancer	6.89e-06	0.00049	CbGpPWpGaD
Posaconazole—Vomiting—Prednisone—hematologic cancer	6.88e-06	2.28e-05	CcSEcCtD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—hematologic cancer	6.84e-06	0.000486	CbGpPWpGaD
Posaconazole—Rash—Prednisone—hematologic cancer	6.83e-06	2.26e-05	CcSEcCtD
Posaconazole—ABCB1—Metabolism—TXN—hematologic cancer	6.82e-06	0.000485	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—ABCC3—hematologic cancer	6.82e-06	0.000485	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—GSTO1—hematologic cancer	6.82e-06	0.000485	CbGpPWpGaD
Posaconazole—Dermatitis—Prednisone—hematologic cancer	6.82e-06	2.26e-05	CcSEcCtD
Posaconazole—Decreased appetite—Doxorubicin—hematologic cancer	6.81e-06	2.26e-05	CcSEcCtD
Posaconazole—Headache—Prednisone—hematologic cancer	6.78e-06	2.25e-05	CcSEcCtD
Posaconazole—Gastrointestinal disorder—Doxorubicin—hematologic cancer	6.76e-06	2.24e-05	CcSEcCtD
Posaconazole—Fatigue—Doxorubicin—hematologic cancer	6.75e-06	2.24e-05	CcSEcCtD
Posaconazole—CYP3A4—Metabolism—PC—hematologic cancer	6.75e-06	0.00048	CbGpPWpGaD
Posaconazole—Urticaria—Epirubicin—hematologic cancer	6.73e-06	2.23e-05	CcSEcCtD
Posaconazole—Constipation—Doxorubicin—hematologic cancer	6.7e-06	2.22e-05	CcSEcCtD
Posaconazole—Pain—Doxorubicin—hematologic cancer	6.7e-06	2.22e-05	CcSEcCtD
Posaconazole—Body temperature increased—Epirubicin—hematologic cancer	6.69e-06	2.22e-05	CcSEcCtD
Posaconazole—Abdominal pain—Epirubicin—hematologic cancer	6.69e-06	2.22e-05	CcSEcCtD
Posaconazole—ABCB1—Metabolism—SPHK1—hematologic cancer	6.67e-06	0.000475	CbGpPWpGaD
Posaconazole—Hypersensitivity—Methotrexate—hematologic cancer	6.67e-06	2.21e-05	CcSEcCtD
Posaconazole—CYP3A4—Metabolism—SLC35B2—hematologic cancer	6.52e-06	0.000464	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—GBA—hematologic cancer	6.52e-06	0.000464	CbGpPWpGaD
Posaconazole—Asthenia—Methotrexate—hematologic cancer	6.49e-06	2.15e-05	CcSEcCtD
Posaconazole—Feeling abnormal—Doxorubicin—hematologic cancer	6.46e-06	2.14e-05	CcSEcCtD
Posaconazole—Nausea—Prednisone—hematologic cancer	6.43e-06	2.13e-05	CcSEcCtD
Posaconazole—ABCB1—Metabolism—UGT1A1—hematologic cancer	6.41e-06	0.000456	CbGpPWpGaD
Posaconazole—Gastrointestinal pain—Doxorubicin—hematologic cancer	6.41e-06	2.12e-05	CcSEcCtD
Posaconazole—Pruritus—Methotrexate—hematologic cancer	6.4e-06	2.12e-05	CcSEcCtD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	6.28e-06	0.000447	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—SLC22A1—hematologic cancer	6.24e-06	0.000444	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—CRABP1—hematologic cancer	6.24e-06	0.000444	CbGpPWpGaD
Posaconazole—Hypersensitivity—Epirubicin—hematologic cancer	6.24e-06	2.07e-05	CcSEcCtD
Posaconazole—Urticaria—Doxorubicin—hematologic cancer	6.22e-06	2.06e-05	CcSEcCtD
Posaconazole—Abdominal pain—Doxorubicin—hematologic cancer	6.19e-06	2.05e-05	CcSEcCtD
Posaconazole—Body temperature increased—Doxorubicin—hematologic cancer	6.19e-06	2.05e-05	CcSEcCtD
Posaconazole—Diarrhoea—Methotrexate—hematologic cancer	6.19e-06	2.05e-05	CcSEcCtD
Posaconazole—ABCB1—Metabolism—ALOX5—hematologic cancer	6.08e-06	0.000432	CbGpPWpGaD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	6.08e-06	0.000432	CbGpPWpGaD
Posaconazole—Asthenia—Epirubicin—hematologic cancer	6.07e-06	2.01e-05	CcSEcCtD
Posaconazole—Pruritus—Epirubicin—hematologic cancer	5.99e-06	1.99e-05	CcSEcCtD
Posaconazole—Dizziness—Methotrexate—hematologic cancer	5.98e-06	1.98e-05	CcSEcCtD
Posaconazole—CYP3A4—Metabolism—MTAP—hematologic cancer	5.96e-06	0.000424	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—NUP98—hematologic cancer	5.89e-06	0.000419	CbGpPWpGaD
Posaconazole—Diarrhoea—Epirubicin—hematologic cancer	5.79e-06	1.92e-05	CcSEcCtD
Posaconazole—Hypersensitivity—Doxorubicin—hematologic cancer	5.77e-06	1.91e-05	CcSEcCtD
Posaconazole—Vomiting—Methotrexate—hematologic cancer	5.75e-06	1.91e-05	CcSEcCtD
Posaconazole—ABCB1—Metabolism—NCOA3—hematologic cancer	5.72e-06	0.000407	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—ADCY7—hematologic cancer	5.72e-06	0.000407	CbGpPWpGaD
Posaconazole—Rash—Methotrexate—hematologic cancer	5.7e-06	1.89e-05	CcSEcCtD
Posaconazole—Dermatitis—Methotrexate—hematologic cancer	5.7e-06	1.89e-05	CcSEcCtD
Posaconazole—ABCB1—Metabolism—NUP214—hematologic cancer	5.68e-06	0.000404	CbGpPWpGaD
Posaconazole—Headache—Methotrexate—hematologic cancer	5.67e-06	1.88e-05	CcSEcCtD
Posaconazole—Asthenia—Doxorubicin—hematologic cancer	5.62e-06	1.86e-05	CcSEcCtD
Posaconazole—Dizziness—Epirubicin—hematologic cancer	5.6e-06	1.86e-05	CcSEcCtD
Posaconazole—ABCB1—Metabolism—MTR—hematologic cancer	5.56e-06	0.000396	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—ABCG2—hematologic cancer	5.56e-06	0.000396	CbGpPWpGaD
Posaconazole—Pruritus—Doxorubicin—hematologic cancer	5.54e-06	1.84e-05	CcSEcCtD
Posaconazole—ABCB1—Metabolism—ENO2—hematologic cancer	5.45e-06	0.000388	CbGpPWpGaD
Posaconazole—Vomiting—Epirubicin—hematologic cancer	5.38e-06	1.78e-05	CcSEcCtD
Posaconazole—Nausea—Methotrexate—hematologic cancer	5.37e-06	1.78e-05	CcSEcCtD
Posaconazole—Diarrhoea—Doxorubicin—hematologic cancer	5.36e-06	1.78e-05	CcSEcCtD
Posaconazole—Rash—Epirubicin—hematologic cancer	5.34e-06	1.77e-05	CcSEcCtD
Posaconazole—Dermatitis—Epirubicin—hematologic cancer	5.33e-06	1.77e-05	CcSEcCtD
Posaconazole—CYP3A4—Metabolism—FHL2—hematologic cancer	5.32e-06	0.000378	CbGpPWpGaD
Posaconazole—Headache—Epirubicin—hematologic cancer	5.3e-06	1.76e-05	CcSEcCtD
Posaconazole—ABCB1—Metabolism—GSTT1—hematologic cancer	5.29e-06	0.000376	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—AGRN—hematologic cancer	5.21e-06	0.000371	CbGpPWpGaD
Posaconazole—Dizziness—Doxorubicin—hematologic cancer	5.18e-06	1.72e-05	CcSEcCtD
Posaconazole—ABCB1—Metabolism—SDC1—hematologic cancer	5.17e-06	0.000368	CbGpPWpGaD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	5.13e-06	0.000365	CbGpPWpGaD
Posaconazole—Nausea—Epirubicin—hematologic cancer	5.03e-06	1.67e-05	CcSEcCtD
Posaconazole—Vomiting—Doxorubicin—hematologic cancer	4.98e-06	1.65e-05	CcSEcCtD
Posaconazole—ABCB1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	4.95e-06	0.000352	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—IDH2—hematologic cancer	4.94e-06	0.000352	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—HMMR—hematologic cancer	4.94e-06	0.000352	CbGpPWpGaD
Posaconazole—Rash—Doxorubicin—hematologic cancer	4.94e-06	1.64e-05	CcSEcCtD
Posaconazole—Dermatitis—Doxorubicin—hematologic cancer	4.93e-06	1.64e-05	CcSEcCtD
Posaconazole—Headache—Doxorubicin—hematologic cancer	4.91e-06	1.63e-05	CcSEcCtD
Posaconazole—Nausea—Doxorubicin—hematologic cancer	4.65e-06	1.54e-05	CcSEcCtD
Posaconazole—CYP3A4—Metabolism—ARNTL—hematologic cancer	4.65e-06	0.000331	CbGpPWpGaD
Posaconazole—ABCB1—Transmembrane transport of small molecules—ALB—hematologic cancer	4.63e-06	0.00033	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—CA9—hematologic cancer	4.52e-06	0.000322	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—ACP5—hematologic cancer	4.52e-06	0.000322	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—NCOR2—hematologic cancer	4.46e-06	0.000317	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—NQO1—hematologic cancer	4.4e-06	0.000313	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—CD44—hematologic cancer	4.4e-06	0.000313	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—IDH1—hematologic cancer	4.25e-06	0.000302	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—ABCC3—hematologic cancer	4.2e-06	0.000299	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—GSTO1—hematologic cancer	4.2e-06	0.000299	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—TXN—hematologic cancer	4.2e-06	0.000299	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—CYCS—hematologic cancer	4.16e-06	0.000296	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—HSP90AA1—hematologic cancer	4.13e-06	0.000294	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—SPHK1—hematologic cancer	4.11e-06	0.000293	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—UGT1A1—hematologic cancer	3.95e-06	0.000281	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—CRABP1—hematologic cancer	3.84e-06	0.000273	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—SLC22A1—hematologic cancer	3.84e-06	0.000273	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—ALOX5—hematologic cancer	3.75e-06	0.000266	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—GSTP1—hematologic cancer	3.67e-06	0.000261	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—NUP98—hematologic cancer	3.63e-06	0.000258	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—ADCY7—hematologic cancer	3.52e-06	0.00025	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—NCOA3—hematologic cancer	3.52e-06	0.00025	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—NUP214—hematologic cancer	3.5e-06	0.000249	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—ABCG2—hematologic cancer	3.43e-06	0.000244	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—MTR—hematologic cancer	3.43e-06	0.000244	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—NCOR1—hematologic cancer	3.37e-06	0.00024	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—GSTM1—hematologic cancer	3.37e-06	0.00024	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—ENO2—hematologic cancer	3.36e-06	0.000239	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—GSTT1—hematologic cancer	3.26e-06	0.000232	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—SDC1—hematologic cancer	3.18e-06	0.000227	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—MTHFR—hematologic cancer	2.98e-06	0.000212	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—NQO1—hematologic cancer	2.71e-06	0.000193	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—CD44—hematologic cancer	2.71e-06	0.000193	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—CYCS—hematologic cancer	2.56e-06	0.000182	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	2.55e-06	0.000181	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—PIK3CG—hematologic cancer	2.5e-06	0.000178	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—CREBBP—hematologic cancer	2.32e-06	0.000165	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—GSTP1—hematologic cancer	2.26e-06	0.000161	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—PIK3CD—hematologic cancer	2.2e-06	0.000156	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—ALB—hematologic cancer	2.17e-06	0.000154	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—ABCB1—hematologic cancer	2.14e-06	0.000152	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—PIK3R1—hematologic cancer	2.08e-06	0.000148	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—GSTM1—hematologic cancer	2.08e-06	0.000148	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—NCOR1—hematologic cancer	2.08e-06	0.000148	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—PIK3CB—hematologic cancer	1.92e-06	0.000136	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—MTHFR—hematologic cancer	1.83e-06	0.00013	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—PTEN—hematologic cancer	1.66e-06	0.000118	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—EP300—hematologic cancer	1.58e-06	0.000112	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.54e-06	0.00011	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.43e-06	0.000102	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.35e-06	9.64e-05	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—ALB—hematologic cancer	1.34e-06	9.51e-05	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.28e-06	9.1e-05	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—PIK3CB—hematologic cancer	1.18e-06	8.4e-05	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—PIK3CA—hematologic cancer	1.17e-06	8.31e-05	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—PTEN—hematologic cancer	1.02e-06	7.26e-05	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—EP300—hematologic cancer	9.73e-07	6.92e-05	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—AKT1—hematologic cancer	9.54e-07	6.79e-05	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—PIK3CA—hematologic cancer	7.2e-07	5.12e-05	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—AKT1—hematologic cancer	5.88e-07	4.18e-05	CbGpPWpGaD
